Monitoring Clinical Quality in Rare Disease Services in England
Author Information
Author(s): Kenny Thomas D, Jessop Edmund G, Gutteridge William H
Primary Institution: National Commissioning Group, Southside, 105 Victoria Street, London, UK
Conclusion
The study discusses the development of systems for monitoring clinical quality in rare disease services in England, emphasizing the need for performance measurement and improvement.
Supporting Evidence
- The study emphasizes the importance of collecting data on all patients to ensure quality care.
- It highlights the need for agreed outcome measures to avoid misunderstandings between service providers and commissioners.
- The authors discuss the challenges of monitoring outcomes for rare diseases due to small patient populations.
Takeaway
This study is about how doctors in England check if they are doing a good job for patients with rare diseases, making sure everyone gets the best care possible.
Methodology
The study describes a system for monitoring clinical quality that includes collecting data on all patients seen each year and agreeing on outcome measures with clinicians.
Potential Biases
There is a risk of misinterpretation of outcome data, especially when comparing different centers.
Limitations
The study notes challenges in interpreting outcome data for rare conditions due to small patient numbers and the need for risk adjustment.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website